← Back to Clinical Trials
Recruiting Phase 4 NCT05080569
Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
Condition Pregnancy Related
Sponsor UMC Utrecht
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 1,008
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2023-03-01
Completion 2025-12
Interventions
Progesterone Vaginal ProductPlacebo
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The LUMO study is a multicenter, randomized controlled trial that evaluates the effectivity of luteal phase support in MOH/IUI treatment.
Eligibility Criteria
Inclusion Criteria: * Couples starting IUI with Mild Ovarian HyperStimulation (MOH), with the intend to receive this treatment for at least six months. * Diagnosis of unexplained (primary or secondary) infertility * Hunault \<30% (or \>30%, after an expectant management period of at least 6 additional months). * Females aged \>18 years with regular menstrual cycle. * Total mobile sperm count (VCM) \>10 million. Exclusion cirteria: * Cycle irregularities * Male factor infertility
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology